Literature DB >> 11815391

Uraemic toxins induce proximal tubular injury via organic anion transporter 1-mediated uptake.

Masaru Motojima1, Atsuko Hosokawa, Hideyuki Yamato, Takamura Muraki, Toshimasa Yoshioka.   

Abstract

A direct effect of uraemic toxins in promoting progression of chronic renal disease has not been established. In this study, we investigated the toxic effects of organic anions which characteristically appeared in the patients with progressive renal disease on renal proximal tubular cells expressing human organic anion transporter (hOAT) 1. A renal proximal tubular cell line, opossum kidney (OK) cells, was transformed with hOAT1. Among the organic anions examined, hippuric acid, para-hydroxyhippuric acid, ortho-hydroxyhippuric acid, indoxyl sulphate and indoleacetic acid showed a high affinity for hOAT1 expressed in the OK cells. Indoxyl sulphate and indoleacetic acid concentration-dependently inhibited proliferation of the hOAT1-transformed cells. The h.p.l.c. analysis demonstrated that cellular uptake of these organic anions was significantly elevated in hOAT1-transformed cells. These organic anions also concentration-dependently stimulated cellular free radical production. The degrees of inhibition of cell proliferation and the stimulation of free radical production induced by the organic anions were significantly higher in the hOAT1-transformed cells than vector-transformed cells. The stimulatory effect of indoxyl sulphate on free radical production was abolished by anti-oxidants and probenecid. Less free radical production was observed in the hOAT1-transformed cells treated with p-hydroxyhippuric acid, o-hydroxyhippuric acid compared with indoxyl sulphate and indoleacetic acid. Hippuric acid had little effect on free radical production. Organic anions present in the serum of patients with progressive renal disease may cause proximal tubular injury via hOAT1-mediated uptake. The mechanism of cellular toxicity by these uraemic toxins involves free radical production. Thus, some uraemic toxins may directly promote progression of chronic renal disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11815391      PMCID: PMC1573145          DOI: 10.1038/sj.bjp.0704482

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

Review 1.  Dietary therapy in uremia: the impact on nutrition and progressive renal failure.

Authors:  W E Mitch
Journal:  Kidney Int Suppl       Date:  2000-04       Impact factor: 10.545

2.  Therapeutic effects of oral sorbent in undialyzed uremia.

Authors:  T Sanaka; N Sugino; S Teraoka; K Ota
Journal:  Am J Kidney Dis       Date:  1988-08       Impact factor: 8.860

Review 3.  Oxidant mechanisms in toxic acute renal failure.

Authors:  R Baliga; N Ueda; P D Walker; S V Shah
Journal:  Drug Metab Rev       Date:  1999-11       Impact factor: 4.518

4.  Elevation of serum levels of beta-aminoisobutyric acid in uremic patients and the toxicity of the amino acid.

Authors:  F Gejyo; Y Kinoshita; T Ikenaka
Journal:  Clin Nephrol       Date:  1977-12       Impact factor: 0.975

5.  Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: comparison with 2',7'-dichlorodihydrofluorescein diacetate, 5(and 6)-carboxy-2',7'-dichlorodihydrofluorescein diacetate, and dihydrorhodamine 123.

Authors:  S L Hempel; G R Buettner; Y Q O'Malley; D A Wessels; D M Flaherty
Journal:  Free Radic Biol Med       Date:  1999-07       Impact factor: 7.376

6.  Oxidative stress contributes to the anti-proliferative effects of flavone acetic acid on endothelial cells.

Authors:  S R Harris; N J Panaro; U P Thorgeirsson
Journal:  Anticancer Res       Date:  2000 Jul-Aug       Impact factor: 2.480

Review 7.  Cellular and molecular aspects of drug transport in the kidney.

Authors:  K I Inui; S Masuda; H Saito
Journal:  Kidney Int       Date:  2000-09       Impact factor: 10.612

8.  Roles of oxygen radical production and lipid peroxidation in the cytotoxicity of cephaloridine on cultured renal epithelial cells (LLC-PK1).

Authors:  K Kiyomiya; N Matsushita; S Matsuo; M Kurebe
Journal:  J Vet Med Sci       Date:  2000-09       Impact factor: 1.267

Review 9.  Protein-bound uremic solutes: the forgotten toxins.

Authors:  R Vanholder; R De Smet; N Lameire
Journal:  Kidney Int Suppl       Date:  2001-02       Impact factor: 10.545

10.  Tryptophan and indolic tryptophan metabolites in chronic renal failure.

Authors:  A Saito; T Niwa; K Maeda; K Kobayashi; Y Yamamoto; K Ohta
Journal:  Am J Clin Nutr       Date:  1980-07       Impact factor: 7.045

View more
  27 in total

Review 1.  Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles.

Authors:  Ahsan N Rizwan; Gerhard Burckhardt
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

Review 2.  The organic anion transporter (OAT) family: a systems biology perspective.

Authors:  Sanjay K Nigam; Kevin T Bush; Gleb Martovetsky; Sun-Young Ahn; Henry C Liu; Erin Richard; Vibha Bhatnagar; Wei Wu
Journal:  Physiol Rev       Date:  2015-01       Impact factor: 37.312

Review 3.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

4.  Gut-derived uremic toxin handling in vivo requires OAT-mediated tubular secretion in chronic kidney disease.

Authors:  Kevin T Bush; Prabhleen Singh; Sanjay K Nigam
Journal:  JCI Insight       Date:  2020-04-09

Review 5.  Uremic toxin and bone metabolism.

Authors:  Yoshiko Iwasaki; Hideyuki Yamato; Tomoko Nii-Kono; Ayako Fujieda; Motoyuki Uchida; Atsuko Hosokawa; Masaru Motojima; Masafumi Fukagawa
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

6.  Alleviation of cisplatin-induced acute kidney injury using phytochemical polyphenols is accompanied by reduced accumulation of indoxyl sulfate in rats.

Authors:  Masahiro Kusumoto; Hiroki Kamobayashi; Daisuke Sato; Megumi Komori; Misato Yoshimura; Akinobu Hamada; Yukimasa Kohda; Kimio Tomita; Hideyuki Saito
Journal:  Clin Exp Nephrol       Date:  2011-08-23       Impact factor: 2.801

7.  Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients.

Authors:  Fellype C Barreto; Daniela V Barreto; Sophie Liabeuf; Natalie Meert; Griet Glorieux; Mohammed Temmar; Gabriel Choukroun; Raymond Vanholder; Ziad A Massy
Journal:  Clin J Am Soc Nephrol       Date:  2009-08-20       Impact factor: 8.237

Review 8.  The gut microbiome, kidney disease, and targeted interventions.

Authors:  Ali Ramezani; Dominic S Raj
Journal:  J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 10.121

Review 9.  Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.

Authors:  Ali Ramezani; Ziad A Massy; Björn Meijers; Pieter Evenepoel; Raymond Vanholder; Dominic S Raj
Journal:  Am J Kidney Dis       Date:  2015-11-15       Impact factor: 8.860

10.  Metabolomics and incident hypertension among blacks: the atherosclerosis risk in communities study.

Authors:  Yan Zheng; Bing Yu; Danny Alexander; Thomas H Mosley; Gerardo Heiss; Jennifer A Nettleton; Eric Boerwinkle
Journal:  Hypertension       Date:  2013-06-17       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.